Calendar MediciNova, Inc.

Equities

MNOV

US58468P2065

Market Closed - Nasdaq Other stock markets 21:00:00 26/04/2024 BST			5-day change	1st Jan Change
1.31 ^USD	-0.76%		-5.76%	-12.67%

03-27	MediciNova, Inc. Receives a Notice of Allowance for a New Patent Covering MN-166 for the Treatment of Macular Injury in Japan	CI
03-12	Medicinova Announces New Data and Results of Mn-166 in Chlorine Gas-Induced Acute Lung Injury Presented At the 63Rd Annual Meeting of the Society of Toxicology	CI

Chart calendar MediciNova, Inc.

e2b799f4.B99dHIfTGparu4ThH7XrDuX7iw3uy6mZAMrpAfgDlCk.cOoOa7-9aaX_zLatftK_a66S_V-i-f_LNImEZcxpp1h0lyds77pUwe3PyQ~725e64e9db108f81db1b32aa9ae9123e

Upcoming events on MediciNova, Inc.

02/06/2024 16:30

American Society of Clinical Oncology Annual Meeting - Abstract Number: 2106

Past events on MediciNova, Inc.

18/11/2023 03:30	Society for Neuro Oncology Meeting
12/06/2023	Annual General Meeting
15/02/2023	World Congress of the Society for Brain Mapping and Therapeutics
27/09/2022	Lytham Partners Fall Investor Conference
14/06/2022 21:00	Annual General Meeting
28/04/2022 18:00	B Riley Securities Virtual Neurology & Ophthalmology Conference
28/03/2022 17:00	Maxim Group Virtual Growth Conference
06/12/2021	ALS MND International Symposium
11/11/2021	AASLD The Liver Meeting
23/10/2021	International Atherosclerosis Symposium
08/09/2021	Morgan Stanley Global Healthcare Conference
13/08/2021 00:00	Interim 2021 Earnings Release
13/07/2021 21:30	Ladenburg Thalmann Healthcare Conference
23/06/2021 18:00	Analyst Meeting - Maxim Group LLC
16/06/2021 21:00	Annual General Meeting
23/05/2021	UBS Global Healthcare Conference
13/05/2021 21:30	Q1 2021 Earnings Release
29/04/2021 18:30	B. Riley Neuroscience Conference
17/03/2021 13:00	Maxim Emerging Growth Conference
12/11/2020	American Association for the Study of Liver Diseases Meeting

Annual results

Fiscal Period	December	2019	2020	2021	2022	2023	2024
Net sales Million USD	Released Forecast Spread	0,00 0,00 -	0,00 0,00 -	4,04 4,01 0.62%	0,00 0,00 -	1,00 1,00 0%	0,00
EBITDA Million USD	Released Forecast Spread	0,00 0,00 -	-14,2 -15,5 8.63%	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00
EBIT Million USD	Released Forecast Spread	-14,0 -15,6 10.06%	-14,2 -15,5 8.3%	-10,2 -12,5 18.21%	-14,6 -15,7 6.53%	-9,90 -11,6 14.65%	-11,3
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-12,9 -14,7 12.05%	-13,9 -14,7 5.63%	-10,1 -12,4 18.31%	-14,1 -15,2 7.46%	-8,57 -10,5 18.4%	-11,3
Net income Million USD	Released Forecast Spread	-12,9 -14,7 11.96%	-13,9 -14,7 5.64%	-10,1 -12,4 18.29%	-14,1 -15,2 7.44%	-8,57 -10,5 18.37%	-11,3
EPS USD	Released Forecast Spread	-0,30 -0,34 11.76%	-0,31 -0,33 6.06%	-0,21 -0,25 17.1%	-0,29 -0,31 4.92%	-0,17 -0,21 19.05%	-0,23
Announcement Date		13/02/20	19/02/21	16/02/22	16/02/23	15/02/24	-

Quarterly results

Fiscal Period	December	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4
Net sales Million USD	Released Forecast Spread	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	1,00 0,00 -	0,00 0,00 -	0,00	0,00	0,00	0,00
EBIT Million USD	Released Forecast Spread	-2,10 -4,39 52.06%	-3,41 -3,87 11.82%	-4,09 -4,33 5.62%	-3,90 -4,20 7.2%	-3,23 -4,25 23.97%	-2,96 -3,50 15.34%	-3,30 -3,70 10.81%	-1,15 -4,00 71.33%	-2,49 -4,20 40.71%	-2,60	-2,80	-2,90	-3,00
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-2,08 -4,35 52.2%	-3,39 -3,87 12.43%	-4,03 -4,33 7.02%	-3,65 -4,20 13.04%	-3,00 -4,15 27.74%	-2,92 -3,30 11.59%	-2,87 -3,50 17.95%	-0,72 -3,80 80.97%	-2,06 -4,00 48.6%	-2,60	-2,80	-2,90	-3,00
Net income Million USD	Released Forecast Spread	-2,08 -4,35 52.14%	-3,39 -3,87 12.43%	-4,03 -4,33 7.02%	-3,65 -4,20 13.04%	-3,00 -4,15 27.68%	-2,92 -3,30 11.59%	-2,87 -3,50 17.95%	-0,72 -3,80 80.97%	-2,06 -4,00 48.52%	-2,60	-2,80	-2,90	-3,00
EPS USD	Released Forecast Spread	-0,04 -0,09 55.56%	-0,07 -0,08 12.5%	-0,08 -0,09 7.7%	-0,07 -0,09 22.22%	-0,06 -0,09 29.41%	-0,06 -0,07 14.29%	-0,06 -0,07 14.29%	-0,01 -0,08 87.5%	-0,04 -0,08 50%	-0,05	-0,06	-0,06	-0,06
Announcement Date		16/02/22	12/05/22	11/08/22	10/11/22	16/02/23	11/05/23	09/08/23	09/11/23	15/02/24	-	-	-	-

Upcoming sector events for MediciNova, Inc.

28/04/2024	HITGEN INC.: Q1 2024 Earnings Release (Projected)
28/04/2024	CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release (Projected)
29/04/2024	DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
29/04/2024	ARVINAS, INC.: Q1 2024 Earnings Release (Projected)
29/04/2024	MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q1 2024 Earnings Release
29/04/2024	WUXI APPTEC CO., LTD.: Q1 2024 Earnings Release
30/04/2024 21:05	EXELIXIS, INC.: Q1 2024 Earnings Release
30/04/2024	SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release
30/04/2024	MACROGENICS, INC.: Q1 2024 Earnings Release (Projected)
30/04/2024	REGENXBIO INC.: Q1 2024 Earnings Release (Projected)

More events

Past sector events for MediciNova, Inc.

25/04/2024	INVENTISBIO CO., LIMITED: Q4 2023 Earnings Release
25/04/2024	SHANGHAI MEDICILON INC.: Q1 2024 Earnings Release (Projected)
25/04/2024	SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release (Projected)
25/04/2024	DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
25/04/2024	SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release
25/04/2024	REMEGEN CO., LTD.: Q1 2024 Earnings Release
25/04/2024 21:05	PTC THERAPEUTICS, INC.: Q1 2024 Earnings Release
25/04/2024 11:30	SAGE THERAPEUTICS, INC.: Q1 2024 Earnings Release
24/04/2024	JIANGSU YAHONG MEDITECH CO., LTD.: Q1 2024 Earnings Release (Projected)
24/04/2024	BIO-THERA SOLUTIONS, LTD.: Q1 2024 Earnings Release (Projected)